Prognosis of Jejunoileal Atresia Treated by Resection and Anastomosis in the Resource-limited Environment
Journal of Indian Association of Pediatric Surgeons · 2026-07 · 31 (4) · 683-687
DOI: 10.4103/jiaps.jiaps_384_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Indian Association of Pediatric Surgeons, online erschienen am 20.05.2026. Verfasst von Salihou Aminou Sadjo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric, Maroua Regional Hospital, Maroua, Cameroon. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
A BSTRACT Background: Jejunoileal atresia is the most common etiology of intestinal mechanical obstruction. Several surgical techniques have been described in the therapeutic approach to this condition. Treatment by resection and anastomosis with or without gastrointestinal tapering remains a life-saving option in our daily practice. The aim of our study was to report the results of the surgical treatment of jejunoileal atresia by resection and anastomosis in the resource-limited environment. Materials and Methods: We carried out a prospective, descriptive study from November 1 st 2021, to October 31 st , 2023, equating to 2 years, in the Pediatric Surgery Department. All the records of newborns aged from day 0 to day 21 with jejunoileal atresia, only treated by resection and anastomosis were included. The parameters studied were age at presentation, sex, gestational age, type of atresia, associated malformations, morbidity, mortality, and follow-up.
Results
A total of 10 newborns were treated. The median age at the presentation was 2.2 days (1 to 4 days). The male sex was predominant with a sex ratio of 7:3. Prematurity was reported in two cases. No antenatal diagnosis was reported. The type I atresia according to the Martin classification was most commonly found (5 cases). Inguinoscrotal hernia and Ladd bands were associated in 1 case each. Resection and anastomosis with intestinal tapering was performed in all newborns. Surgical site infection was noted in 1 case. We recorded three deaths due to sepsis in our series.
Conclusions
In spite of the limitations inherent to low- and middle-income countries region, our current series shows that it is feasible to achieve the acceptable surgical outcomes in neonatal intestinal obstruction due to intestinal atresia. Rigorous adherence to protocols and improvements in the availability of parenteral nutrition are likely to contribute to optimal outcomes in future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric, Maroua Regional Hospital, Maroua, Cameroon.
- Department of Pediatric Surgery, Yaoundé Gynaeco Obstetric and Pediatric Hospital, Cameroon.
- Department of Pediatric Surgery, Maroua Regional Hospital, Maroua, Cameroon.
- Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
Zitieren
APA
Sadjo, S. A., Gacelle, F. K., Haoua, A. P., Salihou, F., Caroline, D. D. E., & Félicien, M. T. F. (2026). Prognosis of Jejunoileal Atresia Treated by Resection and Anastomosis in the Resource-limited Environment. Journal of Indian Association of Pediatric Surgeons, 31(4), 683-687. https://doi.org/10.4103/jiaps.jiaps_384_25
Vancouver
Sadjo SA, Gacelle FK, Haoua AP, Salihou F, Caroline DDE, Félicien MTF. Prognosis of Jejunoileal Atresia Treated by Resection and Anastomosis in the Resource-limited Environment. Journal of Indian Association of Pediatric Surgeons. 2026;31(4):683-687. doi:10.4103/jiaps.jiaps_384_25
BibTeX
@article{Sadjo2026,
author = {Sadjo, Salihou Aminou and Gacelle, Fossi Kamga and Haoua, Abouamé Palma and Salihou, Fadi and Caroline, Dikongué Dikongué Eugenie and Félicien, Mouafo Tambo Faustin},
title = {Prognosis of Jejunoileal Atresia Treated by Resection and Anastomosis in the Resource-limited Environment},
journal = {Journal of Indian Association of Pediatric Surgeons},
year = {2026},
volume = {31},
number = {4},
pages = {683--687},
doi = {10.4103/jiaps.jiaps_384_25}
}
EUVIMED